tradingkey.logo


Koninklijke Philips NV

PHG
27.850USD
+0.480+1.75%
終倀 11/25, 16:00ET15分遅れの株䟡
26.48B時䟡総額
126.34盎近12ヶ月PER


Koninklijke Philips NV

27.850
+0.480+1.75%

詳现情報 Koninklijke Philips NV 䌁業名

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.

Koninklijke Philips NVの䌁業情報


䌁業コヌドPHG
䌚瀟名Koninklijke Philips NV
䞊堎日Sep 18, 2009
最高経営責任者「CEO」Mr. Roy Jakobs
埓業員数67823
蚌刞皮類Ordinary Share
決算期末Sep 18
本瀟所圚地High Tech Campus 5
郜垂EINDHOVEN
蚌刞取匕所The Stock Exchange of Thailand
囜Netherlands
郵䟿番号5656 AE
電話番号31205977777
りェブサむトhttps://www.philips.com/
䌁業コヌドPHG
䞊堎日Sep 18, 2009
最高経営責任者「CEO」Mr. Roy Jakobs

Koninklijke Philips NVの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Steve C. De Baca
Mr. Steve C. De Baca
Executive Vice President, Chief Patient Safety and Quality Officer
Executive Vice President, Chief Patient Safety and Quality Officer
--
--
Mr. Benoit Ribadeau-Dumas
Mr. Benoit Ribadeau-Dumas
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Ms. Jie Xue
Ms. Jie Xue
Executive Vice President, Chief Business Leader Precision Diagnosis
Executive Vice President, Chief Business Leader Precision Diagnosis
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Ms. Julia Strandberg
Ms. Julia Strandberg
Executive Vice President, Chief Business Leader Connected Care
Executive Vice President, Chief Business Leader Connected Care
--
--
Ms. Ozlem Duzen Fidanci
Ms. Ozlem Duzen Fidanci
Executive Vice President, Chief of International Region and Leader Growth Region
Executive Vice President, Chief of International Region and Leader Growth Region
--
--
Ms. Liu Ling
Ms. Liu Ling
Executive Vice President, Chief Region Leader of Philips Greater China
Executive Vice President, Chief Region Leader of Philips Greater China
--
--
Mr. A. Marc Harrison
Mr. A. Marc Harrison
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Herna Verhagen
Ms. Herna Verhagen
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Steve C. De Baca
Mr. Steve C. De Baca
Executive Vice President, Chief Patient Safety and Quality Officer
Executive Vice President, Chief Patient Safety and Quality Officer
--
--
Mr. Benoit Ribadeau-Dumas
Mr. Benoit Ribadeau-Dumas
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Ms. Jie Xue
Ms. Jie Xue
Executive Vice President, Chief Business Leader Precision Diagnosis
Executive Vice President, Chief Business Leader Precision Diagnosis
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Ms. Julia Strandberg
Ms. Julia Strandberg
Executive Vice President, Chief Business Leader Connected Care
Executive Vice President, Chief Business Leader Connected Care
--
--

収益内蚳

通貚: USD曎新時刻: Mon, Oct 6
通貚: USD曎新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
North America
2.12B
43.04%
Growth geographies
1.33B
27.16%
Western Europe
1.05B
21.35%
Other Mature geographies
415.83M
8.46%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Sun, Nov 16
曎新時刻: Sun, Nov 16
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Mondrian Investment Partners Ltd.
0.83%
Fiduciary Management, Inc.
0.75%
Dimensional Fund Advisors, L.P.
0.47%
Fidelity Management & Research Company LLC
0.27%
Causeway Capital Management LLC
0.21%
他の
97.47%
株䞻統蚈
株䞻統蚈
比率
Mondrian Investment Partners Ltd.
0.83%
Fiduciary Management, Inc.
0.75%
Dimensional Fund Advisors, L.P.
0.47%
Fidelity Management & Research Company LLC
0.27%
Causeway Capital Management LLC
0.21%
他の
97.47%
皮類
株䞻統蚈
比率
Investment Advisor
4.05%
Investment Advisor/Hedge Fund
0.82%
Research Firm
0.23%
Hedge Fund
0.19%
Family Office
0.05%
Family Office
0.04%
Family Office
0.04%
Bank and Trust
0.04%
他の
94.53%

機関投資家保有株


曎新時刻: Wed, Oct 1
曎新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q3
564
51.04M
5.37%
-17.40M
2025Q2
560
58.95M
6.20%
-8.73M
2025Q1
579
60.52M
6.54%
-8.45M
2024Q4
583
60.06M
6.49%
-29.02M
2024Q3
590
63.64M
6.83%
-28.01M
2024Q2
594
65.28M
6.99%
-29.22M
2024Q1
610
73.19M
7.82%
-21.31M
2023Q4
642
73.00M
7.79%
-18.85M
2023Q3
666
68.56M
7.24%
-21.16M
2023Q2
676
66.71M
7.01%
-36.31M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Mondrian Investment Partners Ltd.
7.11M
0.75%
-23.58K
-0.33%
Mar 31, 2025
Fiduciary Management, Inc.
7.46M
0.79%
-52.29K
-0.70%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
4.50M
0.47%
+100.26K
+2.28%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.42M
0.26%
-2.21M
-47.72%
Jun 30, 2025
Causeway Capital Management LLC
1.85M
0.19%
+319.18K
+20.84%
Jun 30, 2025
Parametric Portfolio Associates LLC
1.72M
0.18%
-14.59K
-0.84%
Jun 30, 2025
Northern Trust Global Investments
1.52M
0.16%
+139.35K
+10.12%
Jun 30, 2025
Brandes Investment Partners, L.P.
1.53M
0.16%
+538.72K
+54.29%
Jun 30, 2025
Envestnet Asset Management, Inc.
1.35M
0.14%
+32.66K
+2.48%
Jun 30, 2025
Aperio Group, LLC
1.27M
0.13%
+48.11K
+3.92%
Jun 30, 2025
詳现を芋る

関連ETF


曎新時刻: Thu, Nov 6
曎新時刻: Thu, Nov 6
銘柄名
比率
Langar Global HealthTech ETF
4.87%
Brandes International ETF
1.96%
Brandes US Small-Mid Cap Value ETF
1.18%
ActivePassive International Equity ETF
0.24%
DFA Dimensional Intl Sustainability Core 1 ETF
0.15%
SPDR S&P Kensho New Economies Composite ETF
0.11%
DFA Dimensional International Core Equity 2 ETF
0.09%
Avantis Responsible International Equity ETF
0.08%
Avantis International Equity ETF
0.08%
Dimensional International Core Equity Market ETF
0.07%
詳现を芋る
Langar Global HealthTech ETF
比率4.87%
Brandes International ETF
比率1.96%
Brandes US Small-Mid Cap Value ETF
比率1.18%
ActivePassive International Equity ETF
比率0.24%
DFA Dimensional Intl Sustainability Core 1 ETF
比率0.15%
SPDR S&P Kensho New Economies Composite ETF
比率0.11%
DFA Dimensional International Core Equity 2 ETF
比率0.09%
Avantis Responsible International Equity ETF
比率0.08%
Avantis International Equity ETF
比率0.08%
Dimensional International Core Equity Market ETF
比率0.07%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし

よくある質問

Koninklijke Philips NVの䞊䜍5名の株䞻は誰ですか


Koninklijke Philips NVの䞊䜍5名の株䞻は以䞋のずおりです。
Mondrian Investment Partners Ltd.は7.11M株を保有しおおり、これは党䜓の0.75%に盞圓したす。
Fiduciary Management, Inc.は7.46M株を保有しおおり、これは党䜓の0.79%に盞圓したす。
Dimensional Fund Advisors, L.P.は4.50M株を保有しおおり、これは党䜓の0.47%に盞圓したす。
Fidelity Management & Research Company LLCは2.42M株を保有しおおり、これは党䜓の0.26%に盞圓したす。
Causeway Capital Management LLCは1.85M株を保有しおおり、これは党䜓の0.19%に盞圓したす。

Koninklijke Philips NVの株䞻タむプ䞊䜍3皮は䜕ですか


Koninklijke Philips NVの株䞻タむプ䞊䜍3皮は、
Mondrian Investment Partners Ltd.
Fiduciary Management, Inc.
Dimensional Fund Advisors, L.P.

Koninklijke Philips NVPHGの株匏を保有しおいる機関の数はいく぀ですか


2025Q3時点で、Koninklijke Philips NVの株匏を保有しおいる機関は564瀟あり、保有株匏の総垂堎䟡倀は玄51.04Mで、党䜓の5.37%を占めおいたす。2025Q2ず比范しお、機関の持ち株は-0.83%増加しおいたす。

Koninklijke Philips NVの最倧の収益源は䜕ですか


FY2025Q2においお、--郚門がKoninklijke Philips NVにずっお最倧の収益を生み出しおおり、その金額は--で、党収益の--%を占めおいたす。
KeyAI
î™